The US IPO market has really not had a good 2022
IPO proceeds at the New York Stock Exchange fell 93% this year as public offerings dwindle due to inflationary headwinds and rising interest rates, NYSE President Lynn Martin said at a Reuters conference. Fresh listings on the world’s biggest exchange hit an all-time high in 2021 but have suffered a sharp reversal this year due to market volatility. “Our pipeline is tremendous — the reason companies aren't coming to market is because [of] all the volatility in the market,” Martin said.
EGX30 |
13,640 |
+2.9% (YTD: +14.2%) |
|
USD (CBE) |
Buy 24.54 |
Sell 24.61 |
|
USD at CIB |
Buy 24.55 |
Sell 24.61 |
|
Interest rates CBE |
13.25% deposit |
14.25% lending |
|
Tadawul |
10,823 |
-0.7% (YTD: -4.1%) |
|
ADX |
10,545 |
+1.7% (YTD: +24.3%) |
|
DFM |
3,324 |
+0.6% (YTD: +4.0%) |
|
S&P 500 |
4,072 |
-0.1% (YTD: -14.6%) |
|
FTSE 100 |
7,556 |
0.0% (YTD: +2.3%) |
|
Euro Stoxx 50 |
3,978 |
-0.2% (YTD: -7.5%) |
|
Brent crude |
USD 85.57 |
-1.5% |
|
Natural gas (Nymex) |
USD 6.28 |
-6.8% |
|
Gold |
USD 1,809.60 |
-0.3% |
|
BTC |
USD 16,949 |
-0.4% (YTD: -63.4%) |
THE CLOSING BELL-
The EGX30 rose 2.9% at Thursday’s close on turnover of EGP 2.74 bn. Local investors were net buyers. The index is up 14.2% YTD.
In the green: EKH – EGP (+10.1%), AMOC (+9.7%) and Ezz Steel (+6.6%).
In the red: Cleopatra Hospitals (-3.3%), Ibnsina Pharma (-0.6%) and Talaat Moustafa Group (-0.5%).